Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-31.86%
operating margin TTM
-70.52%
revenue TTM
16.44 Thousand
revenue per share TTM
0.07$
valuation ratios | |
|---|---|
| pe ratio | -1.02 |
| peg ratio | -4.84 |
| price to book ratio | 0.70 |
| price to sales ratio | 0.01 |
| enterprise value multiple | -1.13 |
| price fair value | 0.70 |
profitability ratios | |
|---|---|
| gross profit margin | 67.99% |
| operating profit margin | -70.52% |
| pretax profit margin | -31.86% |
| net profit margin | -31.86% |
| return on assets | -23.7% |
| return on equity | -75.26% |
| return on capital employed | -86.84% |
liquidity ratio | |
|---|---|
| current ratio | 1.76 |
| quick ratio | 1.56 |
| cash ratio | 0.68 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 123.93 |
| operating cycle | 172.65 |
| days of payables outstanding | 219.99 |
| cash conversion cycle | -47.35 |
| receivables turnover | 7.49 |
| payables turnover | 1.66 |
| inventory turnover | 2.95 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.39 |
| debt equity ratio | 1.12 |
| long term debt to capitalization | 0.40 |
| total debt to capitalization | 0.53 |
| interest coverage | -2.25 |
| cash flow to debt ratio | -2.92 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.04 |
| cash per share | 0.02 |
| operating cash flow per share | -0.04 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -2.92 |
| short term coverage ratios | -9.80 |
| capital expenditure coverage ratio | -827.79 |
Frequently Asked Questions
When was the last time BioLineRx Ltd. (NASDAQ:BLRX) reported earnings?
BioLineRx Ltd. (BLRX) published its most recent earnings results on 30-09-2024.
What is BioLineRx Ltd.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. BioLineRx Ltd. (NASDAQ:BLRX)'s trailing twelve months ROE is -75.26%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. BioLineRx Ltd. (BLRX) currently has a ROA of -23.7%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BLRX's net profit margin stand at?
BLRX reported a profit margin of -31.86% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BLRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.76 in the most recent quarter. The quick ratio stood at 1.56, with a Debt/Eq ratio of 1.12.